Current Report Filing (8-k)
03 July 2014 - 7:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported) June 30, 2014
CYTOCORE, INC.
(Exact Name of Registrant as Specified in
Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
333-143570 |
36-4296006 |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
4203 SW 34th St. |
|
Orlando, FL |
32811 |
(Address of Principal Executive Offices) |
(Zip Code) |
(407)
996-9631
(Registrant’s telephone number, including
area code)
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
| o | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 30, 2014, Cytocore, Inc. (the
“Company”) received the resignations of Mauro Scimia and Xavier Carbonell (the “Outgoing Directors”) as
directors of the Company. There were no disagreements between the Company and any of the Outgoing Directors on any matter relating
to our operations, policies or practices which led to their resignations.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CYTOCORE, INC. |
|
|
Date: July 2, 2014 |
By: |
/s/ Robert McCullough |
|
|
Robert McCullough |
|
|
Chief Financial Officer |
|
|
|
Himalaya Technologies (PK) (USOTC:HMLA)
Historical Stock Chart
From Apr 2024 to May 2024
Himalaya Technologies (PK) (USOTC:HMLA)
Historical Stock Chart
From May 2023 to May 2024